- Home
- SABS vs HOOK Comparison
SABS vs HOOK Comparison
Compare SABS & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- HOOK
- Stock Information
- Founded
- SABS 2014
- HOOK 2011
- Country
- SABS United States
- HOOK United States
- Employees
- SABS N/A
- HOOK N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- SABS Health Care
- HOOK Health Care
- Exchange
- SABS Nasdaq
- HOOK Nasdaq
- Market Cap
- SABS 19.0M
- HOOK 18.1M
- IPO Year
- SABS N/A
- HOOK 2019
- Fundamental
- Price
- SABS $1.25
- HOOK $0.92
- Analyst Decision
- SABS Strong Buy
- HOOK Buy
- Analyst Count
- SABS 5
- HOOK 4
- Target Price
- SABS $11.40
- HOOK $10.67
- AVG Volume (30 Days)
- SABS 38.1K
- HOOK 51.1K
- Earning Date
- SABS 05-19-2025
- HOOK 05-08-2025
- Dividend Yield
- SABS N/A
- HOOK N/A
- EPS Growth
- SABS N/A
- HOOK N/A
- EPS
- SABS N/A
- HOOK N/A
- Revenue
- SABS $1,322,410.00
- HOOK $43,946,000.00
- Revenue This Year
- SABS N/A
- HOOK N/A
- Revenue Next Year
- SABS $25.00
- HOOK N/A
- P/E Ratio
- SABS N/A
- HOOK N/A
- Revenue Growth
- SABS N/A
- HOOK 118.32
- 52 Week Low
- SABS $1.11
- HOOK $0.88
- 52 Week High
- SABS $5.01
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- SABS 31.17
- HOOK 22.10
- Support Level
- SABS $1.11
- HOOK $1.17
- Resistance Level
- SABS $1.80
- HOOK $1.24
- Average True Range (ATR)
- SABS 0.16
- HOOK 0.09
- MACD
- SABS -0.01
- HOOK -0.00
- Stochastic Oscillator
- SABS 18.42
- HOOK 7.88
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.